Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of SmartTech Group proposed an additional share issue to shareholders

12/5/24 CARM

Rostelecom expects ₽1 trillion in revenue by 2030

12/5/24 RTKM

Shareholders of LUKOIL approved dividends

12/5/24 LKOH

Cherkizovo to increase exports to Saudi Arabia

12/5/24 GCHE

Mikhelson confirms Sibur's preparation for IPO

12/5/24 SIBR

Novatek will further develop LNG projects

12/5/24 NVTK

Rosneft has scheduled the first stage of commissioning of the Vostok Oil project for 2026

12/5/24 ROSN

VTB to acquire about 30 suppliers of equipment for OSK

12/5/24 VTBR

Delimobile opened a showroom for the sale of used cars

12/5/24 DELI

VTB to launch its own DFA platform

12/5/24 VTBR